lattice公司的ECP5-5G系列是低成本低功耗小尺寸的FPGA系列产品,提供高性能特性如增强的DSP架构,高速SERDES和高速源同步接口,以及高达84K逻辑单元的查找表(LUT),支持高达365个用户I/O,高达156个18 x 18乘法器和各种并行I/O标准,特别适...lattice公司的ECP5-5G系列是低成本低功耗小尺寸的FPGA系列产品,提供高性能特性如增强的DSP架构,高速SERDES和高速源同步接口,以及高达84K逻辑单元的查找表(LUT),支持高达365个用户I/O,高达156个18 x 18乘法器和各种并行I/O标准,特别适合用在量大高速低成本的应用如汽车娱乐系统,小型无线基站和低功耗工业视频照相机.本文介绍了ECP5-5G主要特性,框图和ECP5-5G展开更多
lattice公司的ECP5-5G系列是支持5G SERDES和有多达85K LUT的FPGA,支持的5G协议包括PCI Express Gen 2.0,CPRI和JESD204B,能无缝地连接到ASIC和ASSP,主要应用包括照相机,显示器,游戏平台,小性和低端路由器本文介绍了ECP5-5G系列主要特...lattice公司的ECP5-5G系列是支持5G SERDES和有多达85K LUT的FPGA,支持的5G协议包括PCI Express Gen 2.0,CPRI和JESD204B,能无缝地连接到ASIC和ASSP,主要应用包括照相机,显示器,游戏平台,小性和低端路由器本文介绍了ECP5-5G系列主要特性和优势,以及ECP5?PCI Express板主要特性框图,电路图和材料清单.Lattice’s ECP5-5G family is the only FPGA product line supporting展开更多
Dear Editor,Epithelial downgrowth(EDG)is an uncommon and serious complication of intraocular surgery and trauma[1].It is recognized clinically by a translucent membrane on the corneal endothelium or iris.Treatment o...Dear Editor,Epithelial downgrowth(EDG)is an uncommon and serious complication of intraocular surgery and trauma[1].It is recognized clinically by a translucent membrane on the corneal endothelium or iris.Treatment of EDG is controversial and generally has a low success rate.Recent treatment modalities have been invasive and damaging to the anatomy of the eye[1].展开更多
文摘lattice公司的ECP5-5G系列是低成本低功耗小尺寸的FPGA系列产品,提供高性能特性如增强的DSP架构,高速SERDES和高速源同步接口,以及高达84K逻辑单元的查找表(LUT),支持高达365个用户I/O,高达156个18 x 18乘法器和各种并行I/O标准,特别适合用在量大高速低成本的应用如汽车娱乐系统,小型无线基站和低功耗工业视频照相机.本文介绍了ECP5-5G主要特性,框图和ECP5-5G
文摘lattice公司的ECP5-5G系列是支持5G SERDES和有多达85K LUT的FPGA,支持的5G协议包括PCI Express Gen 2.0,CPRI和JESD204B,能无缝地连接到ASIC和ASSP,主要应用包括照相机,显示器,游戏平台,小性和低端路由器本文介绍了ECP5-5G系列主要特性和优势,以及ECP5?PCI Express板主要特性框图,电路图和材料清单.Lattice’s ECP5-5G family is the only FPGA product line supporting
文摘Dear Editor,Epithelial downgrowth(EDG)is an uncommon and serious complication of intraocular surgery and trauma[1].It is recognized clinically by a translucent membrane on the corneal endothelium or iris.Treatment of EDG is controversial and generally has a low success rate.Recent treatment modalities have been invasive and damaging to the anatomy of the eye[1].